Christopher N. Berry

Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin

Christopher N. Berry, Christine Girardot, Catherine Lecoffreo et al. · Thrombosis and Haemostasis · 1994 · 153 citations

Fibrin-bound Human Thrombin, Clot-incorporated Thrombin, Pharmacotherapy +22

SSR182289A, a selective and potent orally active thrombin inhibitor

J.M. Altenburger, Gilbert Lassalle, Mostapha Matrougui et al. · Bioorganic & Medicinal Chemistry · 2004 · 132 citations

Thrombosis, Blood Platelet, Medicine +7

Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding time

Christopher N. Berry, Denise Girard, Sylvette Lochot et al. · British Journal of Pharmacology · 1994 · 86 citations · Full text

Inhibition by Argatroban, a Specific Thrombin Inhibitor, of Platelet Activation by Fibrin Clot-associated Thrombin

Catherine Lunven, Christiane Gauffeny, Catherine Lecoffre et al. · Thrombosis and Haemostasis · 1996 · 38 citations

SSR182289A, a Novel, Orally Active Thrombin Inhibitor: In Vitro Profile and ex Vivo Anticoagulant Activity

Christopher N. Berry, Gilbert Lassalle, Catherine Lunven et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 22 citations